Functional genetic variations in the IL-23 receptor gene are associated with risk of breast, lung and nasopharyngeal cancer in Chinese populations

Carcinogenesis

Volumn 33, Issue 12, 2012, Pages 2409-2416

  Zheng, Jian ^a   Jiang, Lan ^a   Zhang, Liyuan ^b   Yang, Lei ^c   Deng, Jieqiong ^a   You, Yonghe ^a   Li, Na ^a   Wu, Hongchun ^a   Li, Wei ^a   Lu, Jiachun ^c   Zhou, Yifeng ^a  

^a MEDICAL COLLEGE OF SOOCHOW UNIVERSITY   (China)

^b THE SECOND AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^c GUANGZHOU MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CONCANAVALIN A; INTERLEUKIN 23 RECEPTOR;

3' UNTRANSLATED REGION; ALLELE; ARTICLE; BREAST CANCER; CANCER RISK; CHEMICAL ANALYSIS; CHINESE; CONTROLLED STUDY; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; GENOTYPE; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LUNG CANCER; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; NASOPHARYNX CARCINOMA; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; BREAST NEOPLASMS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOTYPE; HUMANS; INTERLEUKIN-17; LUNG NEOPLASMS; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, INTERLEUKIN; RISK; T-LYMPHOCYTES;

EID: 84870333984     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgs307     Document Type: Article

References (50)

1. Parham, C. et al. (2002) A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rbeta1 and a novel cytokine receptor subunit, IL-23R. J. Immunol., 168, 5699-5708.
2. Chen, Z. et al. (2007) Signal transduction pathways and transcriptional regulation in the control of Th17 differentiation. Semin. Immunol., 19, 400-408.
3. Volpe, E. et al. (2008) A critical function for transforming growth factorbeta, interleukin 23 and proinflammatory cytokines in driving and modulating human T(H)-17 responses. Nat. Immunol., 9, 650-657.
4. Romagnani, S. (2008) Human Th17 cells. Arthritis Res. Ther., 10, 206.
5. Iwakura, Y. et al. (2006) The IL-23/IL-17 axis in inflammation. J. Clin. Invest., 116, 1218-1222.
6. Cho, J.H. et al. (2007) The genetics of inflammatory bowel disease. Gastroenterology, 133, 1327-1339.
7. Le Gouvello, S. et al. (2008) High prevalence of Foxp3 and IL17 in MMRproficient colorectal carcinomas. Gut, 57, 772-779.
8. Langowski, J.L. et al. (2006) IL-23 promotes tumour incidence and growth. Nature, 442, 461-465.
9. Fontenot, J.D. et al. (2003) Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat. Immunol., 4, 330-336.
10. Hori, S. et al. (2003) Control of regulatory T cell development by the transcription factor Foxp3. Science, 299, 1057-1061.
11. Kim, J.M. et al. (2007) Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice. Nat. Immunol., 8, 191-197.
12. Voo, K.S. et al. (2009) Identification of IL-17-producing FOXP3+ regulatory T cells in humans. Proc. Natl. Acad. Sci. U.S.A., 106, 4793-4798.
13. Zhang, B. et al. (2012) Immune surveillance and therapy of lymphomas driven by Epstein-Barr virus protein LMP1 in a mouse model. Cell, 148, 739-751.
14. Mumm, J.B. et al. (2011) IL-10 elicits IFNγ-dependent tumor immune surveillance. Cancer Cell, 20, 781-796.
15. Hoenicke, L. et al. (2012) Immune surveillance of senescent cells-biological significance in cancer- and non-cancer pathologies. Carcinogenesis, 33, 1123-1126.
16. Chow, M.T. et al. (2012) Inflammation and immune surveillance in cancer. Semin. Cancer Biol., 22, 23-32.
17. Chen, B. et al. (2011) IL23R +2199A/C polymorphism is associated with decreased risk of certain subtypes of gastric cancer in Chinese: a casecontrol study. Cancer Epidemiol., 35, 165-169.
18. Chu, H. et al. (2012) Potentially functional polymorphisms in IL-23 receptor and risk of esophageal cancer in a Chinese population. Int. J. Cancer. 130, 1093-1097.
19. Chen, J. et al. (2010) A nonsynonymous polymorphism in IL23R gene is associated with risk of gastric cancer in a Chinese population. Mol. Carcinog., 49, 862-868.
20. Zheng, J. et al. (2012) The protective role of polymorphism MKK4-1304 T>G in nasopharyngeal carcinoma is modulated by Epstein-Barr virus' infection status. Int. J. Cancer, 130, 1981-1990.
21. Jiang, L. et al. (2011) A non-synonymous polymorphism Thr115Met in the EpCAM gene is associated with an increased risk of breast cancer in Chinese population. Breast Cancer Res. Treat., 126, 487-495.
22. Yang, L. et al. (2012) A functional polymorphism at microRNA-629-binding site in the 3'-untranslated region of NBS1 gene confers an increased risk of lung cancer in Southern and Eastern Chinese population. Carcinogenesis, 33, 338-347.
23. An, P. et al. (2009) APOBEC3B deletion and risk of HIV-1 acquisition. J. Infect. Dis., 200, 1054-1058.
24. Lyons, A.B. et al. (1995) Are murine marginal-zone macrophages the splenic white pulp analog of high endothelial venules? Eur. J. Immunol., 25, 3165-3172.
25. Wacholder, S. et al. (2004) Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J. Natl. Cancer Inst., 96, 434-442.
26. Vanden Eijnden, S. et al. (2005) IL-23 up-regulates IL-10 and induces IL-17 synthesis by polyclonally activated naive T cells in human. Eur. J. Immunol., 35, 469-475.
27. Chien, M.H. et al. (2012) Interleukin-23 receptor polymorphism as a risk factor for oral cancer susceptibility. Head Neck, 34, 551-556.
28. Zhang, Z. et al. (2010) Association of interleukin-23 receptor gene polymorphisms with risk of ovarian cancer. Cancer Genet. Cytogenet., 196, 146-152.
29. Ahmed, S. et al. (2009) Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2. Nat. Genet., 41, 585-590.
30. Easton, D.F. et al. (2007) Genome-wide association study identifies novel breast cancer susceptibility loci. Nature, 447, 1087-1093.
31. Gold, B. et al. (2008) Genome-wide association study provides evidence for a breast cancer risk locus at 6q22.33. Proc. Natl. Acad. Sci. U.S.A., 105, 4340-4345.
32. Hunter, D.J. et al. (2007) A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nat. Genet., 39, 870-874.
33. Stacey, S.N. et al. (2007) Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancer. Nat. Genet., 39, 865-869.
34. Zheng, W. et al. (2009) Genome-wide association study identifies a new breast cancer susceptibility locus at 6q25.1. Nat. Genet., 41, 324-328.
35. Thomas, G. et al. (2009) A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1). Nat. Genet., 41, 579-584.
36. Bei, J.X. et al. (2010) A genome-wide association study of nasopharyngeal carcinoma identifies three new susceptibility loci. Nat. Genet., 42, 599-603.
37. Yao, Z.Q. et al. (2001) Hepatitis C virus core protein inhibits human T lymphocyte responses by a complement-dependent regulatory pathway. J. Immunol., 167, 5264-5272.
38. Auderset, F. et al. (2012) Redundant Notch1 and Notch2 signaling is necessary for IFNγ secretion by T helper 1 cells during infection with Leishmania major. PLoS Pathog., 8, e1002560.
39. Través, P.G. et al. (2011) The tumor suppressor ARF regulates innate immune responses in mice. J. Immunol., 187, 6527-6538.
40. Kiyotani, K. et al. (2012) A genome-wide association study identifies locus at 10q22 associated with clinical outcomes of adjuvant tamoxifen therapy for breast cancer patients in Japanese. Hum. Mol. Genet., 21, 1665-1672.
41. Zhang, H. et al. (2010) Genome-wide association study identifies 1p36.22 as a new susceptibility locus for hepatocellular carcinoma in chronic hepatitis B virus carriers. Nat. Genet., 42, 755-758.
42. Hu, Z. et al. (2011) A genome-wide association study identifies two new lung cancer susceptibility loci at 13q12.12 and 22q12.2 in Han Chinese. Nat. Genet., 43, 792-796.
43. Wu, C. et al. (2011) Genome-wide association study identifies three new susceptibility loci for esophageal squamous-cell carcinoma in Chinese populations. Nat. Genet., 43, 679-684.
44. Li, Z. et al. (2011) IL-23 receptor regulation by Let-7f in human CD4+ memory T cells. J. Immunol., 186, 6182-6190.
45. Liang, S. et al. (2011) MicroRNA let-7f inhibits tumor invasion and metastasis by targeting MYH9 in human gastric cancer. PLoS ONE, 6, e18409.
46. Kortylewski, M. et al. (2009) Regulation of the IL-23 and IL-12 balance by Stat3 signaling in the tumor microenvironment. Cancer Cell, 15, 114-123.
47. Puré, E. et al. (2005) Breaking down the barriers to cancer immunotherapy. Nat. Immunol., 6, 1207-1210.
48. Zhang, L. et al. (2003) Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer. N. Engl. J. Med., 348, 203-213.
49. Sun, T. et al. (2005) FASL -844C polymorphism is associated with increased activation-induced T cell death and risk of cervical cancer. J. Exp. Med., 202, 967-974.
50. Sun, T. et al. (2008) Functional genetic variations in cytotoxic T-lymphocyte antigen 4 and susceptibility to multiple types of cancer. Cancer Res., 68, 7025-7034.